arrow
D

Désiré Takou

university of yaounde i
H指数:17
被引数:971

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Low burden of clinically relevant anaemia and thrombocytopenia among adolescents living with HIV receiving tenofovir/lamivudine plus dolutegravir: the CIPHER-ADOLA study in Cameroon

在接收替诺福韦/拉米夫定联合多替拉韦治疗的HIV感染青少年中,临床相关的贫血和血小板减少症负担较低:来自喀麦隆CIPHER-ADOLA研究

2025-12-080
PRE
Acquired HIV-1 drug resistance to reverse transcriptase and protease inhibitors among people failing antiretroviral therapy in Cameroon and implications for future treatment options

喀麦隆抗逆转录病毒治疗失败人群中HIV-1对逆转录酶和蛋白酶抑制剂的获得性耐药及其对未来治疗选择的启示

2025-09-300
OAAI
HIV-1 Drug Resistance in Children and Implications for Pediatric Treatment Strategies: A Systematic Review and Meta-analysis

HIV-1耐药性在儿童中的表现及其对儿科治疗策略的影响:一项系统评价和荟萃分析

2025-07-011
OAAI
HIV-1 cross-resistance to second-generation non-nucleoside reverse transcriptase inhibitors among individuals failing antiretroviral therapy in Cameroon: implications for the use of long-acting treatment regimens in low- and middle-income countries

HIV-1对第二代非核苷类逆转录酶抑制剂的交叉耐药性:在喀麦隆抗逆转录病毒疗法失败个体中的研究及其对低收入和中等收入国家长效治疗方案使用的启示

2025-04-280
OA
Gaps, challenges and opportunities towards achieving the 95-95-95 targets in Cameroon: A systematic review and meta-analysis protocol

实现喀麦隆95-95-95目标的差距、挑战与机遇:系统综述与Meta分析方案

2025-02-100
OA
Tenofovir and Doravirine Are Potential Reverse-Transcriptase Analogs in Combination with the New Reverse-Transcriptase Translocation Inhibitor (Islatravir) Among Treatment-Experienced Patients in Cameroon: Designing Future Treatment Strategies for Low- and Middle-Income Countries
2025-01-060
OAAI
HIV susceptibility to second-generation integrase strand transfer inhibitors among people with multidrug resistance: a systematic review and meta-analysis protocol
2025-01-010
OAAI
Empowering adolescents living with perinatally-acquired HIV: tailored CD4+count assessment for optimized care, the EDCTP READY-study
2024-09-200
OAAI
Performance characteristics of INDICAID antigen rapid diagnostic test on SARS-CoV-2 samples during the omicron wave in Cameroon
HELIYON
IF3.6
2024-05-010
OAAI
SARS-CoV-2 genomic surveillance and reliability of PCR single point mutation assay (SNPsig® SARS-CoV-2 EscapePLEX CE) for the rapid detection of variants of concern in Cameroon

SARS-CoV-2基因组监测和PCR单点突变试验的可靠性 (SNPsig®SARS-CoV-2 EscapePLEX CE),用于快速检测喀麦隆的关注变体

HELIYON
IF3.6
2024-04-010
OAAI
Characterization of HIV-1 Reservoirs in Children and Adolescents: A Systematic Review and Meta-Analysis Toward Pediatric HIV Cure
2024-04-010
PRE
Current knowledge of human Mpox viral infection among healthcare workers in Cameroon calls for capacity-strengthening for pandemic preparedness
2024-03-126
OAAI
Evaluation of HIV-1 DNA levels among adolescents living with perinatally acquired HIV-1 in Yaounde, Cameroon: A contribution to paediatric HIV cure research in Sub-Saharan Africa
2024-03-010
OAAI
Characterization of HIV-1 reservoirs in children and adolescents: a systematic review and meta-analysis toward pediatric HIV cure
2023-12-170
OA
Predictors of archived HIV-1 drug resistance mutations in cellular reservoirs of virally suppressed adolescents: the EDCTP READY-study TMA2025-CDF1027
2023-12-170
OA
COVID-19 monitoring in Cameroon reveals men and elderly persons at risk of prolonged duration of positivity: a contribution toward Long-COVID
2023-12-170
OA
Detectable low-level viremia among people living with HIV in Cameroon suggests a revised threshold for viral suppression: evidence in the era of dolutegravir-based ART
2023-12-170
OA
Genomic surveillance of SARS-CoV-2 reveals highest severity and mortality of delta over other variants: evidence from Cameroon
2023-12-083
OAAI
Inflammatory profile of vertically HIV-1 infected adolescents receiving ART in Cameroon: a contribution toward optimal pediatric HIV control strategies
2023-08-141
OAAI